Pfizer files lung cancer drug in US and Japan
May 18, 2011Sales and Marketing NSCLC, Pfizer, crizotinib
Pfizer has submitted its oral lung cancer drug crizotinib for regulatory approval in the US and Japan. Crizotinib is an …
Shire makes $750m regenerative medicines acquisition
May 18, 2011Manufacturing and Production, Research and Development, Sales and Marketing Shire, regenerative medicine
Shire’s ambitions to build a regenerative medicine business will soon be realised following its $750 million acquisition of Advanced BioHealing. …
Mark Dean-Netscher joins Penn Pharma
May 18, 2011Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development
Penn Pharma has appointed Mark Dean-Netscher as its new chief operating officer. He has more than 20 years experience in …
Prime Minister stands by radical NHS shake up
May 17, 2011Health and Social Care Bill, NHS reforms
Prime Minister David Cameron is standing firm on the government’s planned restructuring of the NHS despite mounting opposition. Cameron was …
Lilly accused of anti-competitive practices
May 17, 2011Amylin, Boehringer, diabetes, exenatide, lilly, linagliptin
Amylin Pharmaceuticals is suing Eli Lilly and Company for alleged anticompetitive activity around Lilly’s January agreement with Boehringer Ingelheim to …
Teva plans Japan expansion with Taiyo buy
May 17, 2011Sales and Marketing Taiyo, Teva, generics
Teva is to acquire a majority stake in Taiyo, Japan’s third largest generics company for $460 million in cash. The …
Lonza invests again in Visp high-potency capacity
May 17, 2011Manufacturing and Production APIs, HPAPIs, Lonza, manufacturing and production
Lonza has pushed further into the high-potency active pharmaceutical ingredient (HPAPI) sector with another round of investment at its manufacturing …
HIV drug Prezista recalled on TBA contamination
May 17, 2011Manufacturing and Production HIV, Johnson & Johnson, Prezista, manufacturing and production, recalls
Johnson & Johnson has recalled 11,700 bottles of its HIV treatment Prezista after consumer reports of a mouldy smell caused …
Pharma manufacturing news in brief
May 17, 2011Manufacturing and Production manufacturing and production
There are new facilities for Alexion, Biovest and Pharmascience, a production contract for Dalton Pharma Services and progress in Codexis’ …
Dr Thomas Bieringer to head up Bayer technology centre
May 17, 2011Manufacturing and Production appointment, manufacturing and production
Bayer has appointed Dr Thomas Bieringer as managing director of INVITE GmbH, a joint research venture with the Technical University …
Sanofi strikes Crohn’s deal with Glenmark
May 16, 2011Research and Development Crohn’s disease, Glenmark, Sanofi
Sanofi has signed a deal with Indian drug maker Glenmark Pharmaceuticals to develop a new treatment for Crohn’s Disease. The …
Shield Therapeutics appoints finance chief
May 16, 2011Sales and Marketing appointment, sales and marketing
Swiss specialty pharma company Shield Therapeutics has appointed Richard Jones to the newly-created role of chief financial officer. He has …
Merck’s hepatitis drug Victrelis approved by FDA
May 16, 2011Sales and Marketing Merck & Co, Victrelis, boceprevir, hepatitis C
The FDA has approved Merck’s hepatitis C drug Victrelis, the first oral treatment for the disease. Victrelis (boceprevir) has been …
ABPI and BIA move in together
May 16, 2011Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BIA
The UK’s pharma industry association the ABPI and its biotech equivalent the BIA are jointly relocating to new London offices. …
It’s time we redesigned the clinical trial
May 16, 2011Research and Development clinical trials, randomised controlled trials
Who can remember a time when the pathway from laboratory bench to marketed product didn’t include clinical trial phases I …
Price concession helps change NICE’s mind on Simponi
May 13, 2011Sales and Marketing NICE, Simponi, TNF, merck sharp and dohme
NICE has provisionally recommended Merck Sharp & Dohme’s Simponi for rheumatoid arthritis alongside other drugs in the TNF inhibitor class. …
Takeda denies $12bn Nycomed takeover reports
May 13, 2011Research and Development, Sales and Marketing Nycomed, Takeda
Japan’s biggest pharma firm Takeda has denied reports it is negotiating a billion dollar deal to acquire Swiss speciality firm …
EMA under fire from European Parliament
May 13, 2011Medical Communications, Research and Development, Sales and Marketing EMA, European Parliament, MEPs
The EMA has been hit by a barrage of criticism from the European Parliament over conflicts of interest and the …
Publicis acquires Beijing-based healthcare agency
May 13, 2011Medical Communications Publicis Life Brands Dreams, Publicis Life Brands Watermelon, medical communications agency, publicis
Publicis has acquired Dreams Communication, a Chinese agency specialising in healthcare communications. Dreams will become part of Publicis Healthcare Communications …
NHS Alliance defends GP commissioning
May 13, 2011GP commissioning, NHS Alliance, NHS reforms
The NHS Alliance has issued a staunch defence of the principle of GP commissioning – but warned the government to …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
